YANCOPOULOS GEORGE 1226690 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-13 | 2023-12-11 | 2023-12-11 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | dsp | 12841.0 | 1.68 | 1.2 | 844.09 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 752486.0 | 107.13 (REGN) |
| 2023-12-13 | 2023-12-11 | 2023-12-11 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | acq | 25155.0 | 3.29 | 2.35 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 765327.0 | 107.13 (REGN) |
| 2023-12-13 | 2023-12-11 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 5889.0 | 0 | 0.55 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-13 | 2023-12-11 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 158410.0 | 0 | 14.79 | 0.0 | By 2022 Grat Ii | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-13 | 2023-12-11 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 196848.0 | 0 | 18.37 | 0.0 | By Trust For Chldn. | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-13 | 2023-12-11 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 121071.0 | 0 | 11.3 | 0.0 | By 2022 Grat I | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-02 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 5889.0 | 0 | 0.55 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-02 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 158410.0 | 0 | 14.79 | 0.0 | By 2022 Grat Ii | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | dsp | 16848.0 | 8.56 | 1.57 | 900.0 | By Trust For Chldn. | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 180000.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-02 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 121071.0 | 0 | 11.3 | 0.0 | By 2022 Grat I | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-02 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 752486.0 | 0 | 70.24 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | acq | 172723.0 | 18.67 | 16.0 | 399.66 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 925209.0 | 107.94 (REGN) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | dsp | 123601.0 | 13.36 | 11.45 | 953.83 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 801608.0 | 107.94 (REGN) |
| 2024-02-20 | 2024-02-15 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 180000.0 | 0 | 16.68 | 0.0 | By Trust For Chldn. | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-20 | 2024-02-15 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 158410.0 | 0 | 14.68 | 0.0 | By 2022 Grat Ii | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-20 | 2024-02-15 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 5889.0 | 0 | 0.55 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-20 | 2024-02-15 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 121071.0 | 0 | 11.22 | 0.0 | By 2022 Grat I | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-05-01 | 2024-04-29 | 2024-04-29 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | dsp | 36296.0 | 100.0 | 3.36 | 0.0 | By 2022 Grat I | Common Stock | REGENERON PHARMACEUTICALS, INC. | code G | 0.0 | 107.94 (REGN) |
| 2024-05-01 | 2024-04-29 | 2024-04-29 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | acq | 18148.0 | 100.0 | 1.68 | 0.0 | By Children | Common Stock | REGENERON PHARMACEUTICALS, INC. | code G | 18148.0 | 107.94 (REGN) |
| 2024-05-01 | 2024-04-29 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 180000.0 | 0 | 16.68 | 0.0 | By Trust For Chldn. | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-05-01 | 2024-04-29 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 158410.0 | 0 | 14.68 | 0.0 | By 2022 Grat Ii | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-05-01 | 2024-04-29 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 5903.0 | 0 | 0.55 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-05-01 | 2024-04-29 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 886383.0 | 0 | 82.12 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-05-01 | 2024-01-02 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 5889.0 | 0 | 0.55 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-05-01 | 2024-01-02 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 158410.0 | 0 | 14.68 | 0.0 | By 2022 Grat Ii | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-05-01 | 2024-01-02 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 121071.0 | 0 | 11.22 | 0.0 | By 2022 Grat I | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-05-01 | 2024-01-02 | 2024-01-02 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | dsp | 16848.0 | 8.56 | 1.56 | 900.0 | By Trust For Chldn. | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 180000.0 | 107.94 (REGN) |
| 2024-05-01 | 2024-01-02 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | holding | 752486.0 | 0 | 69.71 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-13 | 2023-12-11 | 2023-12-11 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | dsp | 25155.0 | 100.0 | 2.35 | 0.0 | Direct | 2019 Performance Stock Units | REGENERON PHARMACEUTICALS, INC. | code M | 0.0 | 107.13 (REGN) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Yancopoulos George | BD. CO-CHAIR, PRESIDENT & CSO | dsp | 172723.0 | 100.0 | 16.0 | 399.66 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 0.0 | 107.94 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)